A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer - Concepedia

Concepedia

Publication | Open Access

A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

DOI Full Paper Access

82

Citations

25

References

2011

Year

Elena Ratner, Florence K. Keane, Robert Lindner, Renata Tassi, Trupti Paranjape, Michelle Glasgow, Sunitha Nallur, Yanxiang Deng, Lingeng Lu, Linda Steele,

MedicineKras VariantPathologyGynecologyCancer GenomicsCancer BiologyPlatinum Chemotherapy ResistanceCancer TreatmentMolecular DiagnosticsCancer GeneticsOncologyRadiation OncologyEndocrine-related CancerOvarian Cancer

References

	Year	Citations

Page 1

Page 1